BioCorRx Inc. (OTCMKTS:BICX – Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.98 and traded as high as $1.47. BioCorRx shares last traded at $1.47, with a volume of 200 shares trading hands.
BioCorRx Stock Performance
The company’s 50-day simple moving average is $0.99 and its 200-day simple moving average is $1.10. The stock has a market capitalization of $13.05 million, a price-to-earnings ratio of -3.27 and a beta of 0.59.
About BioCorRx
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Featured Stories
- Five stocks we like better than BioCorRx
- What is the NASDAQ Stock Exchange?
- Comprehensive PepsiCo Stock Analysis
- Trading Stocks: RSI and Why it’s Useful
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.
